"CANCER COMMONS PUTS THE PATIENT AT THE FRONT END OF A REMARKABLE EXPERIMENT... TO WORK OUT PERSONALIZED MEDICAL SOLUTIONS."
PATIENTS, CLOSE THE
We are a patient-centered nonprofit uniting patients, clinicians, and researchers in Rapid Learning Communities. We apply the latest scientific knowledge and tools to recommend the best available treatments, and update that knowledge in real time, based on each patient's response.
We invite patients, researchers, and clinicians to join us by donating data. This open science collaboration will speed discovery. By including patients in the learning loop, we bring new findings about the latest treatments to those who urgently need answers beyond the standard of care.
Bonnie J. Addario
Cancer Survivor; Founder, Bonnie J. Addario Lung Cancer Foundation
Tony Blau, MD
Co-Director of the Institute for Stem Cell and Regenerative Medicine, University of Washington
Frank McCormick, PhD, FRS
Director, UCSF Helen Diller Family Comprehensive Cancer Center
Athlete, Business Owner, and Cancer Fighter
Sibel Blau, MD
Breast Cancer Core Team Leader and Member; Partners in Personalized Oncology (PiPO)
Daniel Kraft, MD
Executive Director of FutureMed; Faculty Chair of Medicine at Singularity University
Cancer Survivor and Tissue Bank Curator
Laura Esserman, MD, MBA
Director of UCSF Carol Franc Buck Breast Care Center; Founding Director, Athena Breast Health Network
Joel Dudley, PhD
Director of Biomedical Informatics, Icahn Institute for Cenomics and Multiscale Biology; Icahn School of...
LATEST CANCER NEWSEnzalutamide in Prostate Cancer: Hints of Added Benefit
“Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have alread...
NEED TO KNOW BLOGS
A recent New York Times article tells the story of one woman’s quest to gain access to an experimental drug to treat her deadly cancer. Her story is familiar to many of us who have heard similar tal...
Choose a blog:
PRESS & EVENTS
Cancer Commons founder Marty Tenenbaum will lead a panel discussion at the 2014 Personalized Medicine World Conference (PMWC) on Jan 27. The discussion, entitled, “PM in Oncology Today: Making It Work for Patients, Clinicians, Researchers, and Industry,” will also feature George Demetri of Dana-Farber/Harvard Cancer Center, Vincent A. Miller of Foundation Medicine, lung cancer s...